The FDA has issued a safety announcement regarding drugs containing Zolpidem (Ambien, Ambien CR, Edular and Zolpimist) that are used in the treatment of insomnia. These drugs can impair driving and other activities that require alertness the morning after a drug has been taken. Women may be particularly sensitive to Zolpidem.
For the complete communication from the FDA, click here.
FDA requires lower doses for Ambien, other sleep meds